Ropivacaine Hydrochloride Injection, Solution
Product Images NDC 65219-632

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ropivacaine Hydrochloride (NDC 65219-632). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Rop09 0001 01)

Figure (Rop09 0001 01)
Chemical structure diagram of Ropivacaine Hydrochloride showing molecular components including aromatic ring, amide link, piperidine ring, and hydrochloride salt.*
FDA Label Image

Fresenius Kabi Logo (Rop09 0001 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ropivacaine Hydrochloride Injection, USP Bag Label)

Package Label (PRINCIPAL DISPLAY – Ropivacaine Hydrochloride Injection, USP Bag Label)
Label for Ropivacaine Hydrochloride Injection, USP 0.2% (2 mg/mL) solution for injection, 100 mL vial. Indicated for infiltration, nerve block, and epidural administration only. Manufactured for Fresenius Kabi USA, LLC. Contains no preservatives and is a single-dose container. Store at 20° to 25°C (68° to 77°F).*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ropivacaine Hydrochloride Injection, USP Overpouch Label)

Package Label (PRINCIPAL DISPLAY – Ropivacaine Hydrochloride Injection, USP Overpouch Label)
Label for Ropivacaine Hydrochloride Injection, USP 0.2% (2 mg per mL, 200 mg per 100 mL) in a 100 mL solution. The label indicates use for infiltration, nerve block, and epidural administration only. Manufactured by Fresenius Kabi USA, LLC, with instructions for sterile single dose use and storage at 20° to 25°C.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ropivacaine Hydrochloride Injection, USP Bag Label)

Package Label (PRINCIPAL DISPLAY – Ropivacaine Hydrochloride Injection, USP Bag Label)
Ropivacaine Hydrochloride Injection, USP 2 mg/mL (0.2%) solution in a 200 mL container, providing 400 mg total. Label states it is for infiltration, nerve block, and epidural administration only. Manufactured for Fresenius Kabi USA, LLC, made in India. Includes storage and usage instructions, barcode, and NDC 65219-632-04.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ropivacaine Hydrochloride Injection, USP Overpouch Label)

Package Label (PRINCIPAL DISPLAY – Ropivacaine Hydrochloride Injection, USP Overpouch Label)
Label for Ropivacaine Hydrochloride Injection, USP 0.2% solution, containing 400 mg per 200 mL (2 mg per mL). The 200 mL bag is indicated for infiltration, nerve block, and epidural administration. Labeled by Fresenius Kabi USA, LLC, with storage instructions and usage warnings, including single dose only and no preservatives.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.